Comparison of an attenuated anticoccidial vaccine and an anticoccidial drug programme in commercial broiler chickens in Italy.
A live attenuated anticoccidial vaccine (Paracox) was compared with a nicarbazin-monensin anticoccidial drug shuttle programme in three crops of Italian broilers, comprising a total of 290,405 chickens. All birds received the antibiotic growth promoter avilamycin. No coccidiosis was evident during the trials, but the occurrence of oocysts in the litter demonstrated that a natural challenge was present. Vaccinated birds consistently performed at least as well as those treated with the anticoccidial drug shuttle. The final mean weights of vaccinated birds were significantly greater (P < 0.001) than those of birds treated with anticoccidial drugs, both for females at 36/37 days and males at 56 days. Feed conversion ratios, total mortality including culls, the proportion of rejects at the processing plant, and the moisture content of the litter were not significantly different between the two control methods. Growth curves showed that there was no post-vaccinal growth check in the vaccinated birds and no intolerance of the anticoccidial drug treatment. There was no overall seasonal effect, regardless of treatment, on the performance of the three crops reared from November 1997 to July 1998. These findings suggest that the use of this vaccine is likely to enable the replacement of anticoccidial drug shuttle programmes in broilers reared under conditions similar to those used in these Italian flocks.
Williams
R B
RB
Schering-Plough Animal Health, Breakspear Road South, Harefield, Uxbridge, Middlesex UB9 6LS, UK. ray.williams@spcorp.com
Gobbi
L
L
D000821:Animal Feed; D000818:Animals; D002645:Chickens; D003048:Coccidiosis / Q000188:drug therapy / Q000517:prevention & control / Q000662:veterinary*; D003049:Coccidiostats / Q000008:administration & dosage / Q000627:therapeutic use*; D004539:Eimeria / Q000276:immunology*; D005260:Female; D007558:Italy; D008297:Male; D008985:Monensin / Q000008:administration & dosage / Q000627:therapeutic use; D009528:Nicarbazin / Q000008:administration & dosage / Q000627:therapeutic use; D009844:Oligosaccharides / Q000008:administration & dosage / Q000627:therapeutic use; D033661:Oocysts / Q000302:isolation & purification; D011201:Poultry Diseases / Q000188:drug therapy / Q000517:prevention & control*; D016052:Protozoan Vaccines; D014611:Vaccination / Q000662:veterinary; D014613:Vaccines, Attenuated; D015430:Weight Gain
D003049:Coccidiostats; D009844:Oligosaccharides; D016052:Protozoan Vaccines; D014613:Vaccines, Attenuated; D009528:Nicarbazin; C006653:avilamycin; D008985:Monensin